RM-718

· Rhythm Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for RM-718, covering 2025-12-22 to 2025-12-22. Get the full timeline:

Most recent: Clinical Trial Update: A Study of RM-718 in Healthy Subjects and Patients With MC4R Pathway Impairment [Phase 1, Phase 2]